Page last updated: 2024-08-23

epirubicin and Jaundice, Cholestatic

epirubicin has been researched along with Jaundice, Cholestatic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boettge, KR; De Santo, G; Paasch, C; Strik, MW1
Chen, Y; Cheng, JM; Gong, GQ; Liu, QX; Liu, R; Luo, JJ; Qian, S; Wang, JH; Wang, XL; Yan, ZP1

Other Studies

2 other study(ies) available for epirubicin and Jaundice, Cholestatic

ArticleYear
Mesenchymal chondrosarcoma metastasising to the pancreas.
    BMJ case reports, 2018, Dec-31, Volume: 11, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cholangiopancreatography, Endoscopic Retrograde; Chondrosarcoma, Mesenchymal; Common Bile Duct; Epirubicin; Humans; Ifosfamide; Ilium; Jaundice, Obstructive; Laminectomy; Magnetic Resonance Imaging; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Radiotherapy, Adjuvant; Ribs; Sacrum; Spinal Fusion; Spinal Neoplasms; Thoracic Vertebrae; Tomography, X-Ray Computed

2018
[Epirubicin in the treatment of malignant obstructive jaundice].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:5

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Jaundice, Obstructive; Liver Neoplasms; Male; Middle Aged; Recurrence; Survival Rate

2006